Prisco Anthony R, Prisco Michael R, Carlson Brian E, Greene Andrew S
Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin; Biotechnology and Bioengineering Center, Medical College of Wisconsin, Milwaukee, Wisconsin;
Exponent Engineering and Scientific Consulting, Biomedical Engineering Practice, Warrenville, Illinois; and.
Am J Physiol Heart Circ Physiol. 2015 Jun 1;308(11):H1368-81. doi: 10.1152/ajpheart.00496.2014. Epub 2014 Dec 24.
Endothelial progenitor cells (EPCs) are a rare population of cells that participate in angiogenesis. To effectively use EPCs for regenerative therapy, the mechanisms by which they participate in tissue repair must be elucidated. This study focused on the process by which activated EPCs bind to a target tissue. It has been demonstrated that EPCs can bind to endothelial cells (ECs) through the tumore necrosis factor-α (TNF-α)-regulated vascular cell adhesion molecule 1/very-late antigen 4 (VLA4) interaction. VLA4 can bind in a high or low affinity state, a process that is difficult to experimentally isolate from bond expression upregulation. To separate these processes, a new parallel plate flow chamber was built, a detachment assay was developed, and a mathematical model was created that was designed to analyze the detachment assay results. The mathematical model was developed to predict the relative expression of EPC/EC bonds made for a given bond affinity distribution. EPCs treated with TNF-α/vehicle were allowed to bind to TNF-α/vehicle-treated ECs in vitro. Bound cells were subjected to laminar flow, and the cellular adherence was quantified as a function of shear stress. Experimental data were fit to the mathematical model using changes in bond expression or affinity as the only free parameter. It was found that TNF-α treatment of ECs increased adhesion through bond upregulation, whereas TNF-α treatment of EPCs increased adhesion by increasing bond affinity. These data suggest that injured tissue could potentially increase recruitment of EPCs for tissue regeneration via the secretion of TNF-α.
内皮祖细胞(EPCs)是参与血管生成的稀有细胞群体。为了有效利用EPCs进行再生治疗,必须阐明它们参与组织修复的机制。本研究聚焦于活化的EPCs与靶组织结合的过程。已证实EPCs可通过肿瘤坏死因子-α(TNF-α)调节的血管细胞黏附分子1/极晚期抗原4(VLA4)相互作用与内皮细胞(ECs)结合。VLA4能以高亲和力或低亲和力状态结合,这一过程很难通过实验从黏附分子表达上调中分离出来。为了分离这些过程,构建了一个新的平行板流动腔,开发了一种解离分析方法,并创建了一个旨在分析解离分析结果的数学模型。该数学模型用于预测在给定的黏附分子亲和力分布下EPC/EC黏附分子的相对表达。用TNF-α/赋形剂处理的EPCs在体外与用TNF-α/赋形剂处理的ECs结合。使结合的细胞受到层流作用,并将细胞黏附量化为剪切应力的函数。以黏附分子表达或亲和力的变化作为唯一自由参数,将实验数据与数学模型进行拟合。结果发现,用TNF-α处理ECs可通过上调黏附分子增加黏附,而用TNF-α处理EPCs则通过增加黏附分子亲和力增加黏附。这些数据表明,受损组织可能通过分泌TNF-α潜在地增加EPCs募集以促进组织再生。